Literature DB >> 25155778

A Rare Cause of Elevated Chitotriosidase Activity: Glycogen Storage Disease Type IV.

Hayriye Hizarcioglu-Gulsen1, Aysel Yuce, Zuhal Akcoren, Burcu Berberoglu-Ates, Yusuf Aydemir, Erdal Sag, Serdar Ceylaner.   

Abstract

Human chitinolytic enzyme named "chitotriosidase" takes part in the defense mechanism against pathogens and the homeostasis of innate immunity. Chitotriosidase was firstly reported to be markedly high in plasma of patients with Gaucher disease. Abnormal lipid laden macrophages are thought to be responsible for stimulating the secretion of chitotriosidase in Gaucher disease. Subsequently, various disorders have also been found to be associated with elevated levels of chitotriosidase. Chronic liver diseases that are also related with macrophage activation may have elevated chitotriosidase activity. We report the second case of the literature with glycogen storage disease (GSD) type IV that presented with high chitotriosidase levels. GSD type IV should be taken into consideration in case of elevated chitotriosidase levels, stigmas of chronic liver disease, and inconsistency of lysosomal storage diseases.

Entities:  

Year:  2014        PMID: 25155778      PMCID: PMC4241209          DOI: 10.1007/8904_2014_335

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  12 in total

1.  Role of chitotriosidase (chitinase 1) under normal and disease conditions.

Authors:  Manasa Kanneganti; Alan Kamba; Emiko Mizoguchi
Journal:  J Epithel Biol Pharmacol       Date:  2012

Review 2.  Neonatal presentation of lethal neuromuscular glycogen storage disease type IV.

Authors:  L F Escobar; S Wagner; M Tucker; J Wareham
Journal:  J Perinatol       Date:  2012-10       Impact factor: 2.521

3.  Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation.

Authors:  Christian Gorzelanny; Birgit Pöppelmann; Karin Pappelbaum; Bruno M Moerschbacher; Stefan W Schneider
Journal:  Biomaterials       Date:  2010-08-24       Impact factor: 12.479

Review 4.  Chitotriosidase: the yin and yang.

Authors:  L Malaguarnera
Journal:  Cell Mol Life Sci       Date:  2006-12       Impact factor: 9.261

5.  Plasma chitotriosidase activity in patients with beta-thalassemia.

Authors:  G Altarescu; B Rudensky; A Abrahamov; A Goldfarb; D Rund; A Zimran; D Elstein
Journal:  Am J Hematol       Date:  2002-09       Impact factor: 10.047

6.  Plasma chitotriosidase activity in children with lysosomal storage disorders.

Authors:  Jayesh J Sheth; Frenny J Sheth; Nrupesh J Oza; Prakash S Gambhir; Usha P Dave; Raju C Shah
Journal:  Indian J Pediatr       Date:  2010-02       Impact factor: 1.967

Review 7.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

8.  Analysis of productive binding modes in the human chitotriosidase.

Authors:  Kristine Bistrup Eide; Anne Rita Lindbom; Vincent G H Eijsink; Anne Line Norberg; Morten Sørlie
Journal:  FEBS Lett       Date:  2013-09-11       Impact factor: 4.124

9.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy.

Authors:  Paul J Orchard; Troy Lund; Wes Miller; Steven M Rothman; Gerald Raymond; David Nascene; Lisa Basso; James Cloyd; Jakub Tolar
Journal:  J Neuroinflammation       Date:  2011-10-20       Impact factor: 8.322

View more
  2 in total

1.  Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.

Authors:  Aparna Sharma; Anu Mary Varghese; Kalyan Vijaylakshmi; Rajendrarao Sumitha; V K Prasanna; S Shruthi; B K Chandrasekhar Sagar; Keshava K Datta; Harsha Gowda; Atchayaram Nalini; Phalguni Anand Alladi; Rita Christopher; Talakad N Sathyaprabha; Trichur R Raju; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

2.  Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities.

Authors:  Edyta Szymańska; Sylwia Szymańska; Grażyna Truszkowska; Elżbieta Ciara; Maciej Pronicki; Yoon S Shin; Teodor Podskarbi; Alina Kępka; Mateusz Śpiewak; Rafał Płoski; Zofia T Bilińska; Dariusz Rokicki
Journal:  Arch Med Sci       Date:  2017-12-19       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.